Thanks for replying. I had a recent pelvic exam and everything seemed fine. Shorty after my initial post, I went back on the Vivelle-Dot and had only mild spotting after three weeks. That week I had forgotten to change my patch for several hours after I should have. So the Vivelle -Dot seems to have alleviated the symptoms. The difference in cost for me is $120 versus $20 for a 3-month mail-order prescription.
I believe the general consensus is sometime towards the middle/end of next year. They have filed for "fast track" approval - so that means it should only take about 4x times longer than it really should, instead of 8x longer.
That's great news. You heard before I did. I'm on the clinical trial. I wonder if they will discontinue the trial once it's approved. Or will they continue the trials until the end? I know TAF is approved to treat HIV now so Hep B was the next step.
While the cost for the substance itself will be drastically lower, once mass production can be used, a weekly infusion in a hospital or clinic is in itself as a procedure very expensive and would shy away insurance carriers or self payers.
For that reason, Replicor rightfully treis to improve on the drug towards a subcutaneous application that can be given to the patient for use at home.
When did you start seeing your doc weekly?
Though vaccine is useless for us now it is coming in my mind y not take it weekly along with my interferon shots. Can it make any difference? Has this thing ever studied on immune change. Any idea or previous study? We have done several self experiments so can this be tried as well but some info on this if any?
Telapravir, once it is approved as a treatment for HepC by the FDA, will be covered, as required by law.
Im 30w4d and my doctor has me going for weekly ultrasounds. That does seem normal and none of family or friends understand it ether. They said the baby was at a health weight.amd length.
//www.thestreet.com/story/11929167/1/2013-fda-drug-approval-calendar.html?cm_ven=GOOGLEN
Gilead Sciences
Drug/indication: Sofosbuvir, hepatitis C
Approval decision date: Dec.
I can tell you that there is currently nothing which is FDA approved for the treatment of Dry Age Related Macular Degneration (Dry AMD). There are lots of studies and trials in the works; seeking FDA approval. I don't know of any which are CE marked for Europe. The current recommendation is weekly amsler grid which can be downloaded free online.
Hello - I am genotype 1a, I had a liver biopsy in February 2014 that showed stage 2 grade 2-3. My IL28B is TT. I found out in Oct 2013 that I relapsed after 48 weeks of triple therapy with Incivek. Prior to that I was a twice non-responder to Interferon and Ribiviran. I've had this disease since 1987 as far as I know.
Today my GI is starting his efforts to get me approved for Harvoni. I'm not sure if I'm considered sick enough for approval or what. I guess I'll find out.
To analyse the antiviral efficacy, hepatitis B transgenic mice were treated either twice-weekly with AIC649 or twice daily with “gold standard” Tenofovir or vehicle over a period of 29 days. Both treatment regimens showed a significant reduction of hepatitis B virus (HBV) titer compared to the control group. Noteworthy, the twice-weekly treatment with AIC649 showed an antiviral effect similar to the twice-daily treatment with Tenofovir.
Recommended
I started my biweekly visits at 27 weeks and I will start my 